How Do You Successfully Translate Complex Clinical Trial Results for Non-Expert Audiences?

Every year, clinical trials produce results that could change how people are treated. But for many patients, carers, and members of the public, those results are hard to find and even harder to understand. Trial reports are long, technical, and full of statistical language.

So how do you successfully translate complex clinical trial results for non-expert audiences? The answer is to combine three things: clinical trial transparency services, plain language writing, and expert redaction services. Together they make results easy to understand, accurate, and safe to share.

Why Clear Communication of Trial Results Matters

People who take part in clinical trials give their time and often accept personal risk to move medical science forward. They deserve to know what the research found.

Regulators agree. The EU Clinical Trials Regulation requires sponsors to provide lay summaries of trial results, and global transparency policies keep growing. When results stay locked inside technical documents, trust falls and people feel shut out of the research they helped to make possible.

Clear communication also supports better decisions. Patients, carers, and doctors can only weigh up a treatment properly if they understand what the evidence shows.

Plain Language Writing: Making Results Understandable

Plain language writing turns scientific content into clear, simple messages without losing accuracy. It is the most important step in reaching a non-expert audience.

A good plain language summary explains why the study was done, who took part, what happened, and what the results mean in everyday life. It uses short sentences, common words, and a logical order that guides the reader from start to finish.

Here are the habits that make plain language writing work. Start by knowing your reader, because a patient, a carer, and a journalist each need something slightly different. Replace jargon with everyday words, and explain any technical term you cannot avoid. Turn statistics into simple comparisons, such as how many people out of one hundred benefited. Be honest about limits and side effects so the summary stays balanced. Finally, ask patient reviewers to read the draft, because they will quickly spot anything that is still confusing.

Plain language writing is not about making content childish. It is about respecting the reader and giving them information they can actually use.

Expert Redaction Services: Protecting Privacy and Confidential Information

Before trial documents are shared publicly, personal data and commercially confidential information must be protected. This is where expert redaction services are essential.

Expert redaction services find and remove details that could identify a trial participant, such as names, dates, rare medical conditions, and site information. They also protect commercially confidential information, so organisations can be open about results without giving away sensitive business details.

Getting the balance right is not easy. Too little redaction puts participant privacy at risk and can breach data protection laws such as GDPR. Too much redaction hides useful scientific information and weakens transparency. Skilled specialists know how to protect what must be protected while keeping the science visible, and they keep a clear record of every decision so the work stands up to regulatory review.

Clinical Trial Transparency Services: Bringing It All Together

Clinical trial transparency services cover the full process of sharing trial information responsibly. This includes registry entries, lay summaries, plain language summaries, and the public release of clinical documents under policies such as the EU Clinical Trials Regulation and EMA disclosure policies.

These services make sure the right information reaches the right audience, at the right time, in the right format. They also connect the other two capabilities. Redaction protects the documents that are published, and plain language writing makes the key findings understandable. Clinical trial transparency services manage the whole journey so nothing is missed and every requirement is met.

How the Three Services Work Together

Think of it as a simple path from complex data to public understanding.

First, the full clinical documents are finalised. Second, expert redaction services protect personal data and confidential information in the documents that will be disclosed. Third, plain language writing turns the main findings into a clear summary for patients and the public. Fourth, clinical trial transparency services publish everything in the right places and keep the records that regulators expect.

When these steps are planned together, the result is faster, more consistent, and far less stressful for study teams. Most importantly, it gives non expert audiences results they can trust and understand.

Why Choose Krystelis

At Krystelis, our mission is to make clinical research crystal clear. Our redaction and anonymisation specialists have supported clinical trial sponsors since 2012, from small biotechs to the largest life sciences companies. Our plain language team creates lay summaries, patient information, and consent materials that real people can follow. And our AI enabled tools, KrystelisClearAI and KrystelisDisclosureAI, help us deliver faster without compromising quality or compliance.

By combining clinical trial transparency services, plain language writing, and expert redaction services in one place, we help you share complex results with confidence.

Ready to make your trial results clear to every audience? Contact Krystelis today for a free consultation.